These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long Noncoding RNA-GAS5: A Novel Regulator of Hypertension-Induced Vascular Remodeling. Wang YN; Shan K; Yao MD; Yao J; Wang JJ; Li X; Liu B; Zhang YY; Ji Y; Jiang Q; Yan B Hypertension; 2016 Sep; 68(3):736-48. PubMed ID: 27432865 [TBL] [Abstract][Full Text] [Related]
10. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II. Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723 [TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Leopold JA; Maron BA Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213345 [TBL] [Abstract][Full Text] [Related]
13. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II. Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833 [TBL] [Abstract][Full Text] [Related]
14. Impaired regulator of G protein signaling 2 transcription facilitates vascular remodeling in injured rat aorta. Mao Y; Su J; Lei L; Meng L; Qi Y; Huo Y; Tang C J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):572-8. PubMed ID: 24914635 [TBL] [Abstract][Full Text] [Related]
16. Adventitial gene transfer of catalase attenuates angiotensin II-induced vascular remodeling. Liu CF; Zhang J; Shen K; Gao PJ; Wang HY; Jin X; Meng C; Fang NY Mol Med Rep; 2015 Apr; 11(4):2608-14. PubMed ID: 25503998 [TBL] [Abstract][Full Text] [Related]
17. Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension. Ten Freyhaus H; Berghausen EM; Janssen W; Leuchs M; Zierden M; Murmann K; Klinke A; Vantler M; Caglayan E; Kramer T; Baldus S; Schermuly RT; Tallquist MD; Rosenkranz S Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1236-45. PubMed ID: 25745058 [TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Zuo L; Ushio-Fukai M; Ikeda S; Hilenski L; Patrushev N; Alexander RW Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1824-30. PubMed ID: 15976327 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension. Baumbach GL; Chillon JM J Hypertens Suppl; 2000 May; 18(1):S7-11. PubMed ID: 10939784 [TBL] [Abstract][Full Text] [Related]
20. Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Antoniak S; Cardenas JC; Buczek LJ; Church FC; Mackman N; Pawlinski R Cardiology; 2017; 136(4):258-268. PubMed ID: 27880950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]